The PREAMBLE registry
Presented by Prof Claudio Cerchione (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Italy)
Prof Dr Claudio Cerchione, a haematologist at the Istituto Romagnolo per lo Studio dei Tumori in Meldola, Italy, shares insights from the PREAMBLE registry. This registry documents treatment patterns and clinical outcomes in MM patients after lenalidomide exposure.
Understanding current real-world treatment patterns and clinical outcomes in patients receiving lenalidomide-containing regimens may help identify unmet needs and optimise future management strategies for these patients.
References:
Cerchione C, EHA2024 #P895
With the educational support of:
